Clinical Impact of Additional Cytogenetic Aberrations, <i>cKIT</i> and <i>RAS</i> Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group
Kim Klein(Erasmus MC), Brenda Gibson(Royal Hospital for Children), Susana C. Raimondi(St. Jude Children's Research Hospital), Martin Zimmerman(Université Paris-Sud), Ardine Reedijk(Netherlands Comprehensive Cancer Organisation), Takashi Taga(Erasmus MC), Betsy Hirsch(Erasmus MC), Anne Auvrignon(Sorbonne Université), Akio Tawa(Erasmus MC), Walentyna Balwierz(Erasmus MC), Gertjan J.L. Kaspers(Amsterdam UMC Location Vrije Universiteit Amsterdam), Michal Zápotocký(Charles University), Alcira Fynn(Erasmus MC), Donna L. Johnston(Children's Hospital of Eastern Ontario), Michael Dworzak(St Anna Children's Hospital), Jeffrey E. Rubnitz(St. Jude Children's Research Hospital), Todd A. Alonzo(University of Southern California), Jacqueline Cloos(Amsterdam University Medical Centers), Barbara De Moerloose(Hôpital Saint-Michel), Andrea Pession(Azienda USL di Bologna), Dirk Reinhardt(Medizinische Hochschule Hannover), H. Berna Beverloo(Erasmus MC), Christine J. Harrison(Newcastle University), Mathilda L. Bongers(Erasmus MC), Vincent Lee(Erasmus MC), А. В. Попа(Erasmus MC), Carmen Salgado(Erasmus MC), Ursula Creutzig(Medizinische Hochschule Hannover), Erik Forestier(Erasmus MC), Bernward Zeller(Erasmus MC)
Cited by 92